ESGO-SIOPE:青少年及年轻成人非上皮性卵巢癌管理指南
欧洲妇科肿瘤学会与欧洲儿科肿瘤学会联合制定循证指南,针对15至25岁青少年及年轻成人非上皮性卵巢癌(含恶性生殖细胞肿瘤、性索间质肿瘤及高钙血症型小细胞癌)的管理。指南基于系统文献综述与多学科专家组严格评价,以保留生育功能及降低急性和长期治疗毒性为重要制定标准,发布前经54名独立国际临床工作者审阅。
要点
- 适用于15至25岁非上皮性卵巢癌患者的管理。
- 涵盖恶性生殖细胞肿瘤、性索间质肿瘤及高钙血症型小细胞癌。
- 保留生育功能与降低治疗毒性是指南制定的重要标准。
核心结论
- ESGO与SIOPE联合发布了针对15至25岁非上皮性卵巢癌患者的循证管理指南。
研究设计与样本
- 指南由ESGO与SIOPE联合制定,基于系统文献综述与严格评价流程。
- 制定组为国际多学科专家组,涵盖儿科肿瘤、儿科外科、肿瘤内科、病理、心理肿瘤、妇科肿瘤及生殖内分泌等学科。
- 发布前由54名独立国际癌症照护从业者审阅。
主要发现
- 指南覆盖恶性卵巢生殖细胞肿瘤、性索间质肿瘤及高钙血症型卵巢小细胞癌。
- 保留生育功能手术及降低治疗相关急性和长期毒性被列为指南定义的重要标准。
临床怎么用
- 临床可参照该指南管理15至25岁非上皮性卵巢癌患者,重点关注保留生育功能与降低治疗毒性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The European Society of Gynaecological Oncology and the European Society for Paediatric Oncology jointly developed clinically relevant and evidence-based guidelines for the management of adolescents and young adults aged 15 to 25 years with non-epithelial ovarian cancers, including malignant ovarian germ cell tumours, sex cord-stromal tumours, and small cell carcinoma of the ovary of hypercalcaemic type. The developmental process of these guidelines is based on a systematic literature review and critical appraisal process involving an international multidisciplinary developmental group consisting of experts from relevant disciplines (paediatric oncology, paediatric surgery, medical oncology, pathology, psycho-oncology, gynaecological oncology, and reproductive endocrinology). Given the specific and often complex issues involved in treating this group of patients, fertility sparing surgery and decrease of acute and long-term toxicities from treatment were important criteria for guidelines definition. Prior to publication, the guidelines were reviewed by 54 independent international practitioners in cancer care delivery.
引用
- Sessa C, Schneider DT, Planchamp F, et al. ESGO-SIOPE guidelines for the management of adolescents and young adults with non-epithelial ovarian cancers. Lancet Oncol. 2020. PMID: 32615119. doi:10.1016/S1470-2045(20)30091-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。